House Democrats recently introduced legislation allowing the FDA to reject devices modeled on previous products that were recalled for safety flaws. The agency currently does not have that authority in every case, which can lead to a question in credibility of some approved devices.
The Advanced Medical Technology Association, meanwhile, argued that the proposed bill would add regulatory burdens for manufacturers who already struggle with lengthy FDA reviews.
Related Articles on Supply Chain:
New Michigan Podiatric Group Looks to Contract Directly With Insurers, Vendors
Medical Technology Delegates Go to Washington
Novation Recognizes 25 Suppliers for Excellence in Service
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.